Launch week offerEnds in00h00m00s

Laura Kytövuori

Has grant

PI 30 %

Tampere University Hospital
Country flagFinland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Mitochondrial dysfunction and unique genetic etiologies in Parkinson's disease - a path to disease-modifying therapies

Open Date: 2026-01-01

Close Date:

Articles (16)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Background and Purpose The biallelic repeat expansion (AAGGG) exp in the replication factor C subunit 1 gene ( RFC1 ) is a frequent cause of cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) as well as late‐onset ataxia. The clinical spectrum of RFC1 disease has expanded since the first identification of biallelic (AAGGG) exp and includes now various nonclassical phenotypes. Biallelic (AAGGG) exp in RFC1 in patients with clinically confirmed Parkinson's disease (PD) has recently been found. Methods A nationwide cohort of 273 Finnish patients with early‐onset PD was examined for the biallelic intronic expansion in RFC1. The expansion (AAGGG) exp was first screened using extra long polymerase chain reactions (Extra Large‐PCRs) and flanking multiplex PCR. The presence of biallelic (AAGGG) exp was then confirmed by repeat‐primed PCR and, finally, the repeat length was determined by long‐read sequencing. Results Three patients were found with the biallelic (AAGGG) exp in RFC1 giving a frequency of 1.10% (0.23%–3.18%; 95% confidence interval). The three patients fulfilled the diagnostic criteria of PD, none of them had ataxia or neuropathy, and only one patient had a mild vestibular dysfunction. The age at onset of PD symptoms was 40–48 years and their disease course had been unremarkable apart from the early onset. Conclusions Our results suggest that (AAGGG) exp in RFC1 is a rare cause of early‐onset PD. Other populations should be examined in order to determine whether our findings are specific to the Finnish population.

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (12)

Valtteri Kaasinen

Professor of Neurology

University of Turku

FINLAND
View details

Jussi Sipilä

University of Eastern Finland

FINLAND
View details

Hiroshi Doi

Associate professor/M.D., Ph.D

Yokohama National University

JAPAN
View details

Tuomas Rauramaa

Senior lecturer

University of Eastern Finland

FINLAND
View details

Aki Hietaharju

Tampere University Hospital

FINLAND
View details

Kari Majamaa

Professor

Oulu University Hospital

FINLAND
View details

Patricia Martínez-Sánchez

Associate Professor of Medicine

Universidad de Almería

SPAIN
View details

Johanna Krüger

Clinical lecturer, Adjunct professor, Research group leader

University of Oulu

FINLAND
View details

Bernard Brais

-

CANADA
View details

Juha Sinisalo

University of Helsinki

FINLAND
View details

Janika Kõrv

Professor in Clinical Neurology

University of Tartu

ESTONIA
View details

Carlo Mario Lombardi

Docenti di ruolo di IIa fascia

University of Brescia

ITALY
View details